Silver Book Fact

Current research supported by the National Institute of Neurological Disease Orders and Stroke (NINDS) at NIH is using animal models to study progression of the disease and develop new drugs therapies; looking for the cause of the disease and continuing to search for environmental and genetic factors; and working to develop new protective drugs that can delay, reverse, or even prevent the disease.

National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH. Parkinson’s Disease Information Page; 2007. http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm

Reference

Title
Parkinson’s Disease Information Page
Publication Date
2007
Authors
National Institutes of Health, National Institute of Neurological Disorders and Stroke, NIH
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Donepezil, a new Alzheimer’s medication, increased prescription costs to $1,000 per patient, however the overall health care costs decreased from $11,947 to $8,056.  
  • Medicines Allow Patients to Remain Independent Longer: New Alzheimer’s medicine delays need for costly home care  
  • According to the Pharmaceutical Research and Manufacturers of America, one of the most promising medicines in development uses normal human cells to enhance brain levels of dopamine, the neurotransmitter deficient…  
  • Valuing a QALY at $175,000, new drugs that would produce a 5-year delay in Alzheimer’s disease onset for all new cases between 2010 and 2050 would yield a benefit of…  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2050 Medicare costs for people with the disease would be…